⌘K
Loading ticker…
As of 2026-08-24, CVS HEALTH CORPORATION (CVS) has a 3-month relative strength percentile of 50 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 54. The current market Stance is 47.8 (Neutral). Sector: Consumer Discretionary, ranked 9 of 11. Average daily range 2.6%, relative volume 1.13×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
CVS appears in 1 ETF as of Jun 2026: WBIG at 0.82% weight, $225K notional.
Held by 300 ETFs · $14.6B across latest filings · largest weight 12.81% (IHF).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| WBIG | 0.82% | $225K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CVS Jan avg: 2.14% median: -5.57% win: 25% σ: 15.79% n: 4 2022-04-12 → 2026-07-31 | CVS Feb avg: 4.57% median: 3.61% win: 75% σ: 9.39% n: 4 2022-04-12 → 2026-07-31 | CVS Mar avg: -2.71% median: -3.51% win: 50% σ: 9.26% n: 4 2022-04-12 → 2026-07-31 | CVS Apr avg: -2.00% median: -1.54% win: 20% σ: 11.52% n: 5 2022-04-12 → 2026-07-31 | CVS May avg: -2.66% median: -4.00% win: 40% σ: 8.09% n: 5 2022-04-12 → 2026-07-31 | CVS Jun avg: 3.58% median: 1.62% win: 60% σ: 7.15% n: 5 2022-04-12 → 2026-07-31 | CVS Jul avg: 0.89% median: 2.15% win: 80% σ: 6.64% n: 5 2022-04-12 → 2026-07-31 | CVS Aug avg: 0.63% median: -1.27% win: 50% σ: 13.04% n: 4 2022-04-12 → 2026-07-31 (current) | CVS Sep avg: 4.30% median: 5.10% win: 75% σ: 5.52% n: 4 2022-04-12 → 2026-07-31 | CVS Oct avg: -2.10% median: -0.93% win: 25% σ: 5.83% n: 4 2022-04-12 → 2026-07-31 | CVS Nov avg: 3.72% median: 4.42% win: 75% σ: 4.02% n: 4 2022-04-12 → 2026-07-31 | CVS Dec avg: -4.64% median: -4.89% win: 25% σ: 17.08% n: 4 2022-04-12 → 2026-07-31 |